Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
5
×
biotech
clinical trials
5
×
life sciences
national
national blog main
national top stories
new york top stories
novartis
5
×
san francisco top stories
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
abbvie
boston top stories
allergan
astrazeneca
bristol-myers squibb
cancer
cancer immunotherapy
crispr
What
bio
roundup
drug
fda
ipo
new
news
acquisitions
america
announced
approval
approved
atrophy
august
biogen
biogen’s
biopharmaceutical
biotech
busy
ceo
collabs
companies
continues
convo
convoluted
covid
daily
daniel
days
deal
decisions
democrats
devices
dreams
drugs
earlier
evrysdi
failures
friday
gilead
Language
unset
Current search:
novartis
×
" clinical trials "
×
biogen
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More